Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,681 to 1,700 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of epigenetic modification in interferon treatment of hepatitis B virus infection. | Front Immunol | 2022 | 36325353 | PubTator, text mining | PubMed |
| Progress in the application of body fluid and tissue level mRNAs-non-coding RNAs for the early diagnosis and prognostic evaluation of systemic lupus erythematosus. | Front Immunol | 2022 | 36325322 | PubTator, text mining | PubMed |
| Characterization of m6A-related lncRNA signature in neuroblastoma. | Front Pediatr | 2022 | 36324814 | PubTator, text mining | PubMed |
| Integrated single-cell and transcriptome sequencing analyses determines a chromatin regulator-based signature for evaluating prognosis in lung adenocarcinoma. | Front Oncol | 2022 | 36324565 | PubTator, text mining | PubMed |
| Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence. | Front Genet | 2022 | 36324506 | PubTator, text mining | PubMed |
| N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3. | Clin Transl Med | 2022 | 36324258 | PubTator, text mining | PubMed |
| N6-methyladenosine RNA modification promotes viral genomic RNA stability and infection. | Nat Commun | 2022 | 36323720 | PubTator, text mining | PubMed |
| RNA m6A methylation regulators in endometrial cancer (Review). | Int J Oncol | 2022 | 36321774 | PubTator, text mining | PubMed |
| Downregulation of METTL14 improves postmenopausal osteoporosis via IGF2BP1 dependent posttranscriptional silencing of SMAD1. | Cell Death Dis | 2022 | 36319624 | PubTator, text mining | PubMed |
| WTAP Targets the METTL3 m6A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection. | J Virol | 2022 | 36314819 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma. | Front Endocrinol (Lausanne) | 2022 | 36313774 | PubTator, text mining | PubMed |
| The development of a novel signature based on the m6A RNA methylation regulator-related ceRNA network to predict prognosis and therapy response in sarcomas. | Front Genet | 2022 | 36313417 | PubTator, text mining | PubMed |
A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment. | Front Immunol | 2022 | 36311770 | PubTator, text mining | PubMed |
| m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer. | J Transl Med | 2022 | 36309694 | PubTator, text mining | PubMed |
| RNA binding proteins in MLL-rearranged leukemia. | Exp Hematol Oncol | 2022 | 36307883 | PubTator, text mining | PubMed |
| The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. | Cancer Cell | 2022 | 36306790 | PubTator, text mining | PubMed |
| NLRP3-mediated pyroptosis in diabetic nephropathy. | Front Pharmacol | 2022 | 36304156 | PubTator, text mining | PubMed |
| Development and validation of a m6A -regulated prognostic signature in lung adenocarcinoma. | Front Oncol | 2022 | 36303829 | PubTator, text mining | PubMed |
| Acetaminophen changes the RNA m6A levels and m6A-related proteins expression in IL-1β-treated chondrocyte cells. | BMC Mol Cell Biol | 2022 | 36303109 | PubTator, text mining | PubMed |
| Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer. | Front Oncol | 2022 | 36300085 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=85